|
Supplementary Protection Certificate (SPC) Summary of Applications |
|||
| SPC No. | 2016/057 | ||
|---|---|---|---|
| Date of filing | 20/12/2016 | ||
| Notification of Application Published | 25/01/2017 | ||
| Status | Withdrawn | ||
| Notification of Grant Published | |||
| Date of Expiry of SPC | |||
| Applicant |
JANSSEN SCIENCES IRELAND UC Eastgate Village, Eastgate Little Island Co. Cork IRELAND |
||
| Patent Number | 1663240 | ||
| Title of Invention | COMBINATIONS OF A PYRIMIDINE CONTAINING NNRTI WITH RT INHIBITORS | ||
| Date of Expiry of Patent | 02/09/2024 | ||
| Product Type | Medicinal Product | ||
| Product Identity | A combination of: rilpivirine or a therapeutically equivalent form thereof protected by the basic patent, such as a pharmaceutically acceptable salt of rilpivirine, including the hydrochloride salt of rilpivirine; and tenofovir alafenamide, or a pharmaceutically acceptable salt thereof, in particular tenofovir alafenamide fumarate. | ||
| Market Authorisation | Ireland | ||
| Authorisation No | EU/1/16/1112 | ||
| Authorisation Date | 21/06/2016 | ||
| Identity of Product Authorised | Odefsey-emtricitabine/rilpivirine/tenofovir alafenamide | ||
| Address for Service |
FRKelly Waterways House Grand Canal Quay Dublin D02 PD39 IRELAND |
||
| Renewal Fees | |||
| 03/01/2017 | Request for grant a Supplementary Protection Certificate filed on 20/12/2016, numbered 2016/057. | ||
| 21/01/2022 | Request for grant of Supplementary Protection Certificate No. 2016/057 withdrawn on 21/01/2022. | ||